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Three Top Benefits of Lean Practice
Workflows
By Jose Santiago-Rivera, MD
About the author: Jose Santiago-Rivera, MD, is a
physician at LVPG Internal Medicine–1255 Cedar
Crest.
It's been nearly a year since we implemented "lean"
workflow principles in our practice, and we’ve seen
significant improvements. We now manage care
through “teamlets,” which pairs a provider (a
physician or physician assistant) with a “flow
manager” (a medical assistant or nurse), who share
a common workspace or “flow station.” Flow
managers organize the provider’s day to prioritize
time, eliminate inefficiencies and make sure patients
get the most value out of their visits.
New care model
Here are three benefits we’ve realized from this new
model of care:
Better teamwork: Communication is clear, fast
and continuous. The teamlets start each
morning with a clinical huddle to go through the day’s schedule, and they move through the day as a unit, with
the flow manager ensuring that every moment of the provider’s time is well spent.
More efficient completion of paperwork: Flow managers make sure that patient forms are mostly filled in
before the provider receives them and directs the paperwork to where it needs to go. We now have many
fewer incidences of lost or duplicated forms, and less time is spent on paperwork overall.
Stronger patient relationships: To give patients more quality time with their providers, we’ve stepped up our
pre-visit planning. Flow managers will call patients about a week before their appointments to go over their
goals for the visit and remind them of any tests that need to be completed before they come in. Patients know
who their regular provider’s medical assistant or nurse is, and they appreciate being able to interact with the
same team.
A committed team
Our transition to this care model was not without its challenges. For example, it took some trial and error to
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determine the best location for the flow stations to offer privacy as well as easy communication with the rest of the
office. But our entire team was committed to making this work, and we’re happy to say we are a better, stronger
practice as a result.
LVPG Internal Medicine–1255 Cedar Crest practice director Ceil Sherman and clinical coordinator Nicole
Pietrobon contributed to this article.
To learn more about Patient-Centered Medical Homes at LVHN, call 888-402-LVHN.
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New Hematology Oncology Center Opens in
Lehighton
Patients in Carbon County who need chemotherapy and other infusion services have access to a new, cutting-
edge oncology center, LVPG Hematology Oncology–Lehighton, located at 363 N. First St. in Lehighton. “The new
facility (which opened in September) demonstrates our commitment to the Carbon community and our passion for
delivering high-quality care to our patients,” says Dan Popescu, MD, a board-certified hematologist oncologist with
Lehigh Valley Health Network (LVHN).
Compared to the former infusion facility at 800 Mahoning St. in Lehighton, where providers had been serving
patients in the Lehigh Valley and Palmerton areas for more than 30 years, the new cancer center “is a bigger
facility that’s designed to put the care and comfort of our patients first,” says Mary Greenberg, director, LVPG
Hematology Oncology.
The new center features the latest in infusion equipment, six exam rooms, eight treatment chairs, an infusion
pharmacy, a private infusion room and a private parking lot for improved patient access. There also will be an
expanded physician presence. Patients will have access to a specialist five days per week, including Dan
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Popescu, MD, Basil Ahmed, MD, and Surendra Shah, MD. Shah opened the first hematology oncology office in
the Lehigh Valley more than three decades ago.
Patients who received services at the Mahoning Street facility will be automatically transferred to the new location
and new patients are always welcome. “We’re the same providers, nurses and office staff that patients are used
to, but in a more convenient location with state-of-the-art facilities,” Popescu says.
To refer a patient for hematology oncology services, call 610-402-CARE.
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Health Center at Mountain Top Offers New
Services
To make quality health care more convenient for patients of the Mountain Top area, Lehigh Valley Health Network
(LVHN) Health Center at Mountain Top is growing. The premier outpatient facility, which opened in March 2016,
recently added oncology, obstetrics and occupational health to its roster of health services so that patients can
access quality care close to home or work.
Multiple services under one roof
The Health Center at Mountain Top now provides:
Primary care from LVPG Family Medicine providers Mark Radziewicz, DO, and Laura Herbener, CRNP.
Oncology services, featuring LVPG Hematology Oncology providers Michael Evans, MD and Harvey
Hotchner, MD.
Cardiology services. The facility offers adult and pediatric electrocardiograms and Holter and event
monitoring, as well as stress tests and echocardiograms for adults under the direction of LVPG Cardiology
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provider Yaqoob Mohyuddin, MD.
Obstetrics and gynecological care featuring LVPG Obstetrics and Gynecology provider Jill Snyder, DO, and
LVPG gynecology provider Mary Ellen Lyons, PA-C.
Rehabilitation, imaging and lab work
The Health Center at Mountain Top also provides rehabilitative physical and occupational therapy, occupational
health treatment, imaging services including adult and pediatric diagnostic X-rays and diagnostic, vascular and
obstetric ultrasounds, laboratory/blood work and telehealth services in conjunction with Lehigh Valley Hospital–
Hazleton.
Located at 237 S. Mountain Blvd., Suite 7, in Mountain Top, the Health Center at Mountain Top is just 14 miles
north of the LVHN Cancer Center–Hazleton on Route 309.
To learn more about the Health Center at Mountain Top, call 610-402-CARE.
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LVHN Clinical Trial Shows Sequential
Immunotherapy Improves Outcomes
Study results published in Lancet Oncology
A clinical trial conducted at Lehigh Valley Health
Network (LVHN) and eight other academic medical
centers in the U.S. demonstrates that sequential
administration of immune checkpoint inhibitors
benefits patients with advanced melanoma.  The
study results, published in the July issue of Lancet
Oncology, are part of a growing body of evidence
supporting the use of checkpoint inhibitors as
frontline therapies in oncology.
New oncology pathway
The phase 2 trial, which enrolled 140 patients with
unresectable stage III or IV melanoma, found that
twice as many patients (41 percent) responded to
administration of nivolumab (Opdivo®) followed by
ipilimumab (Yervoy®) as compared to the reverse
sequence (20 percent).  Disease progression at 13
and 26 weeks was significantly improved with
nivolumab followed by ipilimumab (38 percent vs. 61
percent, 38 percent vs. 60 percent), as was 12-
month overall survival (76 percent vs. 54 percent).
Nivolumab and ipilimumab are anti-PD-1 and anti-
CTLA-4 drugs that enhance the immune system’s response to tumor cells.
“This trial was a major breakthrough,” says hematologist oncologist Suresh Nair, MD, with LVPG Hematology
Oncology–1240 Cedar Crest, medical director of the LVHN Cancer Institute and an author of Lancet Oncology
article. “At the start of the trial, 90 percent of patients with stage IV melanoma were dying within a year. Today,
these medications are FDAapproved for combined use, and the melanoma survival rate has nearly doubled.”
Prior to the start of the clinical trial in 2013, LVHN patient Richard Dey’s stage IV melanoma diagnosis meant that
he likely had only months to live. Treatment with nivolumab and ipilimumab resulted in Nair declaring him cancer
free within six months, and the checkpoint inhibitor therapy was discontinued in 2015.
“We have more than 20 patients with similar success stories at LVHN,” Nair says. “For a cancer researcher like
Suresh Nair, MD
Hematology oncology
Watch a video to learn more about him.
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me, these are exhilarating times. Coming to work each day at LVHN is an adventure because we’re discovering
new ways to treat many types of cancer through clinical trials.”
Oncology research
The checkpoint inhibitor trial is one of dozens of clinical trials conducted at LVHN, and that number will continue to
increase with LVHN Cancer Institute’s membership in the Memorial Sloan Kettering (MSK) Cancer Alliance. In
addition to providing access to key MSK clinical trials, the alliance includes adoption of MSK standards for
oncology care and clinical collaboration among oncologists at both institutions. LVHN and MSK also share
educational resources by collecting and tracking data on quality of care, outcomes and patient satisfaction.
1. "Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced
melanoma (CheckMate 064): an open-label, randomized, phase 2 trial." J. Weber et al. Lancet Onc. 2016;
17(7): 943-955.
To refer a patient for a clinical trial, call 610-402-CARE.
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Promoting Cutting-Edge Lung Cancer Care
Most cancer centers strive to use the latest evidence-based standards of care to guide diagnosis and treatment.
But how many have put in place a formal infrastructure to make sure that’s the case?
Lehigh Valley Health Network’s (LVHN) disease management teams (DMTs) continually evaluate and implement
the latest evidence-based clinical pathways for virtually every cancer disease site.
And LVHN specialists don’t just review standards internally. They validate them with internationally renowned
experts at Memorial Sloan Kettering (MSK) Cancer Center as part of the MSK Cancer Alliance.
This process benefits patients with any cancer type but is particularly important for thoracic and pulmonary
cancers.
“So much has changed in lung cancer therapies, especially over the last five years” says Megan Derr, MSN, RN,
oncology quality and evidence-based practice specialist. “Traditionally, when new information comes out of larger
academic institutions, it can take years to reach community settings. Unless you have a setting like this, with all
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the key players at the table reviewing standards together on an ongoing basis, it’s very hard to make change. We
have a framework that allows us to continually make treatment easier, more efficient and higher quality for our
patients.”
Raising the bar
The thoracic and pulmonary disease DMT includes
many of the same specialists as LVHN’s lung
cancer multidisciplinary clinic (MDC). But where
MDCs focus on coordinating treatment for individual
patients, the DMT evaluates the program overall. It
includes every specialty involved in thoracic and
pulmonary cancer – medical oncology, surgical
oncology, thoracic surgery, radiation oncology,
pulmonary medicine, diagnostic radiology, pathology
and others.
“It’s very important that all of the disciplines
involved, both diagnostic and therapeutic, are
working together to shape our program,” says Eliot
Friedman, MD, who leads the DMT. “It’s the only
way to ensure that we are giving the most effective,
efficient and targeted care to our patients without
wastage, that we’re keeping up with the latest
standards and that we’re all on the same page on
improving our care for lung cancer.”
The thoracic and pulmonary disease DMT analyzes
59 metrics across LVHN’s lung cancer practices.
And the process is ongoing – the team members
meet monthly, as well as discuss care standards
with their counterparts at MSK on a regular basis.
“We look at everything from imaging and surgical
resection to how frequently we’re giving radiation, to
issues of follow-up treatment and support for
survivors,” Derr says. “We also discuss clinical trials
–what’s accruing, if there are any difficulties, if there
are new opportunities coming from MSK or
pharmaceutical companies. We look at the total
spectrum.”
Diagnosis and staging
These reviews also extend to diagnosis and staging.
“As an interventional pulmonologist, my role on the
team is to review how we’re getting a diagnosis,
Eliot L. Friedman, MD
Hematology-Medical Oncology
Robert J. Kruklitis, MD, PhD
Pulmonary/Critical Care Medicine
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before oncologists or surgeons ever get involved,”
says Robert Kruklitis, MD, chief of pulmonary medicine and director of interventional pulmonary medicine at
LVHN. “How do we obtain biopsies? What is the safest, simplest and most effective way to get the information we
need? People might not think of pulmonologists as essential members of a lung cancer team, but it’s one of our
strengths at LVHN that we build very comprehensive teams with representatives from all of the different
specialties.”
One example of the effects of the DMT process: all prospective lung cancer patients at LVHN now undergo
mediastinum staging early in the diagnostic process to provide the most accurate staging possible.
Ongoing review and validation
One of the more unique aspects of the DMTs is that LVHN validates its standards of care against MSK, one of the
leading cancer centers in the world.
“When we began this process, we had very high concordance with the standards that MSK had set for itself, and
I’m very proud that our lung cancer program closely mirrors what patients would get there,” Friedman says.
That relationship is ongoing. LVHN specialists continue to collaborate with their counterparts at MSK to review
changing standards, discuss difficult cases and, when necessary, obtain second opinions. The DMT also
evaluates and integrates new information coming out from national organizations such as the National
Comprehensive Cancer Network (NCCN) and the American Society of Clinical Oncology (ASCO).
“When our treatment team members return from national meetings, all new practice-changing information is
shared and discussed at the DMT meetings,” Derr says. “We also continually evaluate our standards against new
NCCN evidence blocks as they’re released. Things change so rapidly, it’s essential to have this ongoing review of
our program and processes to make sure we’re providing the best care to patients.”
The end result: Whenever patients with lung and thoracic cancers come to LVHN, they can be confident that
they’re getting the very latest, state-of-the-art, evidence-based care.
“This type of ongoing review of standards with independent third-party validation is extremely rare,” Friedman
says. “I don’t believe it’s happening anywhere else.”
To refer a patient for cancer care, call 610-402-CARE.
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Infusion catheter and ultrasonic core
Ultrasound-Accelerated Thrombolysis for
Massive/Submassive PE
EKOS technology provides nonsurgical option for high-risk patients
A new type of catheter-based intervention that uses
ultrasound to promote clot fragmentation and better
penetration of thrombolytic therapy is being adopted
by more hospitals to provide less invasive treatment
options for patients with massive or submassive
pulmonary emboli (PE). “Ultrasoundaccelerated
thrombolysis is a potentially noteworthy new option
for massive/submassive PE patients who are not
candidates for surgical embolectomy,” says James
Burke, MD, PhD, Lehigh Valley Health Network
(LVHN) interventional cardiologist and associate
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chief, division of cardiology.
Most patients with PE are treated with anticoagulant
therapy (i.e., a form of heparin, or
fondaparinux). Options for managing the small
minority (~5 percent) of patients with massive PE
(i.e., systolic blood pressure [SBP] <90 mm Hg)
include thrombolytic therapy (i.e., alteplase),
catheter-based interventions, and surgical
embolectomy. Patients with submassive PE (SBP
≥90 mm Hg and either right ventricular dysfunction
myocardial necrosis) also may be candidates for
these interventions. Catheter-based modalities
include clot aspiration and fragmentation as well as
delivery of a thrombolytic agent directly to the clot.
Ultrasonic catheter
One new ultrasonic device, the EkoSonic®
Endovascular System (EKOS) includes wires with
ultrasonic catheters. A cardiologist or radiologist
inserts the catheters and wires into the left and right
femoral veins, through the heart and left and right
pulmonary arteries. Ultrasound is then transmitted
through the catheter. The ultrasonic catheters and
wires remain in the patient, delivering lytic therapy
for 12 to 24 hours. The patient is then returned to
the catheterization lab to have the ultrasonic
catheter removed.
Because this technology serves a narrow niche of
high-risk patients (Burke estimates there are only
about 1,000 cases nationally each year of this type of PE), data supporting this intervention are sparse, Burke
says. Most publications report single-center series or cases, Burke says. “People were looking for something to
help when really nothing else helps. That’s how this (technology) came into being,” he says.
A retrospective single-center series reported 95 percent survival to discharge (57/60) and 93 percent (56/60)
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survival at 90-day follow-up, with complete (>90 percent) thrombus clearance in 57 percent and near-complete (50
to 90 percent) clearance in 41 percent of patients following ultrasonic accelerated thrombolysis and infusion of lytic
therapy for a mean of 19.6 hours.
Choosing the best therapy
Patients who are candidates for catheter-based interventions or surgery often have multiple risk factors and
comorbid conditions, Burke says. Surgical embolectomy opens the artery faster, says James Wu, MD, chief,
section of cardiac surgery. But “surgery carries its own risks,” Burke says. “Each patient is somewhat different,
and it requires a multidisciplinary team to come up with the best therapy.”
“With these new technologies, we know that one specialty cannot handle the entire spectrum of care,” Wu says. “A
lot of our programs are multispecialty.”
At LVHN, that team includes representation from pulmonary/critical care, cardiology, cardiac surgery, and
interventional cardiology or interventional radiology. Current guidelines also recommend interdisciplinary
consultation when choosing the most appropriate intervention for each patient.  Among the parameters evaluated
are clot size and location, immediate clinical condition, risk for bleeding and the patient’s ability to withstand the
risk of surgery, Burke says.
LVHN plans to make EKOS ultrasound-accelerated thrombolysis available in early 2017. Burke estimates that
LVHN will see only three to five candidates per year for this intervention. Although that is a small number, “we felt
that it was worth having, because it would be lifesaving for those who needed it,” Burke says.
Hospitals that currently utilize EKOS include Massachusetts General and other hospitals with advanced programs
in treating PE.
1. Jaff MR, McMurtry MS, Archer SL, et al. Management of Massive and Submassive Pulmonary Embolism,
Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension: A Scientific
Statement From the American Heart Association. Circulation.2011;123(16):1788-1830.
2. Lapner ST, Kearon C. Diagnosis and management of pulmonary embolism. BMJ.2013;346:f757.
3. Ouellette DR. Pulmonary Embolism. Updated January 30, 2015;
http://emedicine.medscape.com/article/300901-overview#showall. Accessed May 26, 2015.
4. Kennedy RJ, Kenney HH, Dunfee BL. Thrombus resolution and hemodynamic recovery using ultrasound-
accelerated thrombolysis in acute pulmonary embolism. J. Vasc. Interv. Radiol.2013;24(6):841-848.
5. Shah KJ, Scileppi RM, Franz RW. Treatment of pulmonary embolism using ultrasound-accelerated
thrombolysis directly into pulmonary arteries. Vasc. Endovascular Surg.2011;45(6):541-548.
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A New Name for LVPG Orthopedics
As of Jan. 1, 2017, LVPG Orthopedics was renamed LVPG Orthopedics and Sports Medicine to better reflect the
variety of services and treatment options offered by the practice.
LVPG Orthopedics and Sports Medicine offers the full spectrum of orthopedic care for children through adults. All
physicians are certified by the American Board of Orthopedic Surgery and have sub-specialty expertise in hip and
knee joint replacement, sports medicine, orthopedic trauma, pediatric orthopedics, foot and ankle, and chiropractic
care.
The four practice locations include:
LVPG Orthopedics and Sports Medicine–1250 Cedar Crest
1250 S. Cedar Crest Blvd., Allentown, PA 18103
LVPG Orthopedics and Sports Medicine–Muhlenberg
2649 Schoenersville Road, Suite 201, Bethlehem, PA 18017
LVPG Orthopedics and Sports Medicine–Moselem Springs
Routes 222 and 662, Fleetwood, PA 19522
LVPG Orthopedics and Sports Medicine–Health & Wellness Center (Hazleton)
50 Moisey Drive, Hazle Township, PA 18202
Orthopedic Surgeon Returns to the Lehigh Valley - Lehigh Valley Health Network - A Passion For Better Medicine
https://www.lvhn.org/for_referring_physicians/better_medicine/orthopedics/orthopedic_surgeon_returns_to_the_lehigh_valley[5/29/2018 12:25:18 PM]
Orthopedic Surgeon Returns to the Lehigh
Valley
Emphasis on sports medicine, including ACL reconstruction
An anterior cruciate ligament (ACL) injury is a
season-ender for most high school and college
athletes.
But with timely diagnosis and treatment, roughly 80
percent of them will be able to return to their
previous level of play within six to 12 months. Gabe
Lewullis, MD, a sports medicine orthopedic surgeon,
recently joined LVPG Orthopedics to help sports
participants in the Lehigh Valley with ACL and other
injuries safely get back on the field as soon as
possible.
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Hometown Hero
Lewullis, a former assistant team physician for the
Boston Celtics and clinical staff physician at Harvard
University Health Services and Tufts University
School of Medicine, grew up in Allentown, where he
was a basketball star at Allentown Central Catholic
High School. “I wanted to get the chance to give
back to the community that gave me so much,”
Lewullis says.
As a 6-foot, 6-inch college freshman, Lewullis went down in sports history when he led the Princeton University
Tigers to victory over the defending national champion, UCLA, in the opening round of the 1996 NCAA
Tournament by scoring a layup with 3.9 seconds left. After Princeton, Lewullis completed his medical training at
Drexel University College of Medicine and an orthopedic sports medicine fellowship at New England Baptist
Hospital.
He comes to Lehigh Valley Health Network (LVHN) from Bayhealth Medical Center in Dover, Del., where he was
the team physician for multiple high schools and colleges in the area, including Delaware State University and
Wesley College.
ACL Repair
At LVHN, Lewullis will serve the general orthopedic population, with an emphasis on sports medicine, including
ACL reconstruction. An ACL tear is a common noncontact injury among football, basketball and soccer players
that involves a pivot-shift mechanism. Symptoms often include sharp pain around the lateral aspect of the knee
and acute effusion (fluid which is often blood in the knee joint).
“Patients will also often describe a pop that occurs at the time of injury,” Lewullis says.
An X-ray and MRI are used to confirm diagnosis, rule out fracture and evaluate the degree of ligament, meniscus
and cartilage involvement.
If surgery is indicated, Lewullis will reconstruct the ACL with hamstring tendon or bone patella bone autograft or
allograft. “Currently, we don’t repair a torn ACL,” Lewullis says. “We replace it.” The arthroscopic, minimally
invasive, same-day procedure typically takes an hour in the OR. Patients begin physical therapy the next day and
Gabriel Lewullis, MD
Orthopedic Surgery
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continue for three to five months, including home exercises to optimize recovery and outcome.
Restoring knee stability is the ultimate name of the game. “For the majority of athletes, it typically takes a year of
playing before they feel confident going out and doing what they did prior to the injury,” Lewullis says.
To refer a patient for sports medicine treatment, call 888-402-LVHN.
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New Staff Member Expands Capabilities of
LVPG Urology
Fellowship-trained urologist specializes in complex cases for female patients
The arrival of urologist Maria Voznesensky, MD,
with LVPG Urology–1250 Cedar Crest  at Lehigh
Valley Health Network (LVHN) brings expertise in
the subspecialty of female urology and genitourinary
reconstruction. The number of female urologists
such as Voznesensky is increasing, but represents
only eight to 12 percent of urologists in the United
States despite the fact that female urological
patients are growing in number and prefer to be
treated by female urologists.
Pelvic floor disorders
Voznesensky specializes in the complete
management of female pelvic floor disorders.
Damage to the pelvic floor can be caused by
childbirth, chronic disease, surgery or repeated
heavy lifting. Common pelvic floor disorders include
issues related to urinary incontinence, retention,
frequency, nocturia and infection.
In addition, Voznesensky, who completed a
fellowship in female urology and genito-urinary
reconstruction at the University of Iowa, treats
female patients for more complicated urinary
incontinence (UI) issues such as fistula and
prolapse. “Dr. Voznesensky expands our ability to
meet the health needs of women and make a
difference in the community,” says urologic surgeon
Angelo Baccala, MD, chief, division of urology,
Lehigh Valley Health Network (LVHN). “Her
fellowship means that complex cases can be treated
here in an expert, comprehensive manner.”
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diagnostic, therapeutic and surgical procedures
necessary for the total care of female patients with
these conditions, complications and sequelae
resulting from pelvic floor disorders. Although
urologic conditions impact women of all ages, a
growing number of women are seeking treatment
from urologists due to incontinence associated with
aging.  Baccala expects that approximately 80 percent of Voznesensky’s caseload will be female.
Voznesensky’s other practice areas include male incontinence, urethral stricture disease, sexual dysfunction and
general urology. She is experienced in both robotic and open urologic surgery. “It’s important to find the best
solution for the individual patient, and Dr. Voznesensky will further our efforts to personalize care,” Baccala says.
1. “The gender divide: The impact of surgeon gender on surgical practice patterns in urology.” D. Oberlin et al.
J Urol. 2016; epub available at jurology.com/article/S0022-5347(16)30386-X/abstract.
To refer a patient for urologic treatment, call 610-402-CARE.
Fall 2016
Angelo Baccala Jr., MD
Urology
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Children's Hospital Provides Neonatal
Surgery for Intestinal Disease
Hirschsprung's disease requires frequent, ongoing monitoring
Hirschsprung's disease is a disorder that occurs one
in 5,000 live births. Timely diagnosis and surgical
treatment are necessary to decrease morbidity and
mortality.  Surgery for this intestinal condition is
available at Lehigh Valley Children’s Hospital.
Etiology, symptoms
The disease occurs when nerve cells normally
present in the intestine do not form properly during
fetal development. Hirschsprung’s may occur
spontaneously or be inherited, with 20 percent of
cases occurring in multiple members of the same
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family.  Defined by the region where nerve cells are
missing, approximately 80 percent of people
diagnosed with Hirschsprung’s have short-segment
disease that affects the last segment, or
rectosigmoid region, of the large intestine.  Long-
segment disease is more severe in that nerve cells
are lacking in most of the large intestine.  Surgery
is required for all Hirschsprung’s cases.
"Hirschsprung's can be deadly if there’s a delay in treatment, and this is a long-term condition that clinicians work
closely with families to manage," says Marybeth Browne, MD, surgical director of Lehigh Valley Children’s
Hospital.
Symptoms of long-segment disease typically emerge during the first few weeks of life, while chronic progressive
constipation in short-segment disease may not present for months or years.
Hirschsprung's symptoms may include absence of bowel movement during first 48 hours of life, progressive
abdominal distention, gradual onset of bilious vomiting and fever. Children who do not have early symptoms may
present with constipation that becomes worse over time, loss of appetite, delayed growth and passing of small,
watery stools.
Surgical treatment at Children’s Hospital
Green vomit and abdominal distention were warning signs that prompted the transfer of an infant male born in
May 2015 at Lehigh Valley Hospital to the neonatal intensive care unit.
Following diagnosis of long-segment disease, Browne performed a laparoscopic diverting colostomy. The baby
then underwent a laparoscopicassisted transanal Swenson pull-through approximately three months later. Browne
saw the baby every two-four weeks after his surgeries, and moved to three-month intervals once whole milk was
introduced. She will continue to monitor him every six months between ages 2-5, and annually until adulthood.
"He's doing very well, and is meeting all of his milestones despite the two surgeries," Browne says. "Offering this
surgery at Children’s Hospital is so important for the families of children with Hirschsprung's because of the need
for frequent checkups. Driving to Philadelphia or another location would be a major burden."
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ghr.nlm.nih.gov/condition/hirschsprung-disease.
To refer a patient to Children’s Hospital, call 610-402-CARE.
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Successful Collaboration in Maternal Fetal
Medicine, Cardiology, OB/GYN
Heart and Pregnancy Program provides high-risk care for patient with long QT syndrome
Careful medical management of patients with Long
QT Syndrome (LQTS), a cardiac electrical activity
disorder, is necessary to reduce the risk of
malignant arrhythmia.  A multidisciplinary team of
specialists at the Lehigh Valley Health Network
(LVHN) Heart and Pregnancy Program (HPP)
recently developed a successful pre-, peri- and
postoperative management plan for a long QT
patient in her second pregnancy.
High-risk pregnancies
More women with congenital or acquired cardiac
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disease are reaching reproductive age and
achieving pregnancy, requiring complex care that
addresses both cardiovascular and maternal-fetal
health.  HPP is the largest program of its kind in
Pennsylvania, and LVHN’s group of high-risk
pregnancy specialists is one of the largest in the
country.  HPP was established in 2010 as part of
LVHN’s Heart and Vascular Program for Women,
which provides specialized care and prevention of
heart disease in women at all stages of life.
LVHN’s comprehensive team approach includes
maternal fetal medicine (MFM) specialist Joanne
Quiñones, MD, and cardiologist Amy Ahnert, MD,
with LVPG Cardiology. “A multidisciplinary approach
allows for improved communication among team
members caring for the patient, offering the
opportunity to plan ahead for case scenarios which
may occur unexpectedly,” Quiñones says. “This
allows for questions to be addressed before the
patient comes for delivery and everyone can be
more comfortable with a case that is more
complicated than most.”
Long QT case
Brittanee Gibson was a mother of one child when
she was clinically diagnosed with long QT syndrome
in October 2013 after experiencing a cardiac arrest.
Genetic testing for the condition was negative.
Gibson was managed on a hypothermia protocol,
followed by placement of an automatic implantable
cardioverter defibrillator (AICD). She was also
started on nadolol, a beta blocker medication.
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her second pregnancy, Gibson experienced sudden
syncope while doing dishes. ICD interrogation
showed sinus tachycardia 150 beats per minute
prior to syncope, then polymorphic ventricular
tachycardia. At the time, her device effectively
terminated the arrhythmia.
Ahnert and Quiñones assumed Gibson’s care
following that event, working closely with obstetrics.
The patient’s medication dose was increased, and
she was monitored closely at LVHN’s Heart and
Pregnancy Program for the remainder of the
pregnancy. A multidisciplinary plan was developed
by members of cardiology, MFM, anesthesia, labor and delivery, and cardiac nursing to plan for the intrapartum
and postpartum care of this patient, considering her needs for telemetry, medication compliance and medication
alerts given her history of long QT syndrome and risk of malignant arrhythmia.
Clinical relationships
“Multidisciplinary meetings are held every month to review specific cases and draw up care plans that are well-
documented and clear,” says Kristin Friel, MD, LVPG Obstetrics and Gynecology–1245 Cedar Crest . “By nurturing
these clinical relationships, we’re able to provide the level of care that these complex cases demand.”
Gibson’s prenatal course was otherwise unremarkable and she underwent a planned repeat cesarean delivery at
39 weeks. Gibson, 29, delivered a healthy baby girl, who weighed 5 pounds, 10.8 ounces (2575 g), on July 14,
2016.
Counseling and assessment
Women with known cardiac disease or risk factors ideally should receive evaluation and counseling prior to
conception or early in pregnancy.  While early diagnosis and counseling are important, a majority of women
referred to the HPP, including Gibson, are pregnant. The LVHN team has experience treating pregnant patients
with conditions such as congenital heart block, prosthetic heart valves, bicuspid aortic valves, hypertrophic
cardiomyopathy, Marfan syndrome and inherited arrhythmias such as catecholaminergic polymorphic ventricular
tachycardia and long QT syndrome and, among others.
Using personal and family health history, imaging and other assessments, the multidisciplinary team identifies and
quantifies risks to mother and fetus. Cardiac and obstetric issues such as medication exposure, mode of delivery
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Labor and delivery increases cardiac output, making it potentially the most dangerous period for pregnant women
with cardiac disease. The HPP care team conducts simulations to prepare for deliveries by women with cardiac
disease. Taught by cardiology fellows, the simulations include residents, MFM specialists, nursing staff from the
labor and delivery unit and progressive care unit (PCU), anesthesiology and other providers. Simulation related to
anesthesiological management is essential for long QT patients such as Gibson. Despite use of beta blockers,
patients with long QT syndrome undergoing surgical or anesthetic procedures are increased risk of perioperative
arrhythmias.
Long QT case postpartum
Ahnert evaluated Gibson 10 days postpartum, and referred her back to the LVHN cardiologist responsible for her
care before her second pregnancy. “She’s done quite well, but physical and emotional stress during pregnancy
and postpartum increase the risk of a cardiac event,” Ahnert says. “Sleep deprivation and changing hormones are
aggravating factors so it’s important to have a good social support system and regular post-partum care.”
1. “Drugs to be avoided in patients with long QT syndrome: Focus on the anaesthesiological management.” G.
Fazio et al. World J Cardiol. 2013; 5(4): 87-93. 2.
2. “Management of cardiovascular diseases during pregnancy.” V. Regitz-Zagrosek et al. Curr Probl Cardiol.
2014; 39(4-5): 85-151.
3. “High-risk pregnancy care.” Lehigh Valley Health Network website. Available at
www.lvhn.org/conditions_treatments/womens_health/pregnancy/learn_about_pregnancy/high_risk_pregnancy_care
.
4. “Management of hypertension before, during, and after pregnancy.” P.R. James et al. Heart. 2004; 90(12),
1499-504.
To refer a patient to the Heart and Pregnancy Program, call 610-402-CARE.
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